PTGS2 and gastric cancer: Artesunate significantly inhibited gastric cancer cell proliferation in a time- and dose-dependent manner and induced the apoptosis of gastric cancer cells in a dose-dependent manner, and this apoptotic effect was found to be associated with decreased COX-2 expression (133).